Annual report pursuant to Section 13 and 15(d)

Stock Compensation

v3.7.0.1
Stock Compensation
12 Months Ended
Dec. 31, 2016
Stock Compensation [Abstract]  
Stock Compensation

NOTE 9 – STOCK COMPENSATION



2011 Executive Incentive Compensation Plan



On March 28, 2011 the Board adopted and on May 19, 2011 the Company’s shareholders approved the Company’s 2011 Executive Incentive Compensation Plan (“2011 Incentive Plan”).  The 2011 Incentive Plan authorizes incentive awards to officers, key employees and non-employee directors in the form of options (incentive and non-qualified), stock appreciation rights, restricted stock, restricted stock units, performance stock units (“deferred stock”), performance cash units, and other awards in stock, cash, or a combination of stock and cash.  On May 21, 2015, the Company’s shareholders approved an amendment to the 2011 Incentive Plan to increase the authorized shares by 1,000,000 to 2,000,000. As a result, up to 2,000,000 shares of our common stock may be issued pursuant to awards under the 2011 Incentive Plan, as amended.    



During 2016, stock options covering 325,968 shares were awarded to key executive employees and non-employee directors, which options expire seven years from the date of award and vest 25% each year beginning one year after the date of award.  The Company also granted deferred stock awards of 93,828 shares to key employees during 2016 under the Company’s long-term incentive plan for the 2016 to 2018 period. The actual number of shares of deferred stock, if any, that are ultimately earned by the respective employees will be determined based on achievement against performance goals for each of the three years ending December 31, 2018 and the shares earned will be issued in the first quarter of 2019 to those key employees still with the Company at that time.    



At December 31, 2016,  137,583 shares have been issued under the 2011 Incentive Plan, 1,026,094 shares are subject to currently outstanding options, deferred stock awards, and unvested restricted stock units, and 836,323 shares remained available for future issuance under the 2011 Incentive Plan.



Stock Option Plan for Directors



Shares of common stock are reserved for issuance to non-employee directors under options granted by the Company prior to 2011 under its Stock Option Plan for Non-Employee Directors (the “Director Plan”).  Under the Director Plan nonqualified stock options to acquire 3,000 shares of common stock were automatically granted to each non-employee director concurrent with annual meetings of shareholders in 2010 and earlier years and vested immediately. The exercise price of options granted was the fair market value of the common stock on the date of the respective shareholder meetings.  Options granted under the Director Plan expire 10 years from date of grant.   



The Director Plan was suspended as of May 19, 2011 to prohibit automatic option grants in 2011 in connection with seeking and receiving shareholder approval of the 2011 Incentive Plan, at the 2011 Annual Meeting of Shareholders. As shareholder approval was received, the Board amended the Director Plan to prohibit any future option awards under that plan on August 11, 2011. As of December 31, 2016, there were 63,000 shares subject to outstanding options under the Director Plan.



1992 Stock Plan



Under the Company’s 1992 Stock Plan (“the Stock Plan”), shares of common stock may be issued pursuant to stock options, restricted stock or deferred stock grants to officers and key employees. Exercise prices of stock options under the Stock Plan cannot be less than fair market value of the stock on the date of grant. Rules and conditions governing awards of stock options, restricted stock and deferred stock are determined by the Compensation Committee of the Board of Directors, subject to certain limitations in the Stock Plan. When seeking approval of the 2011 Incentive Plan at the 2011 Annual Meeting of Shareholders, the Company committed to amending the Stock Plan to prohibit the issuance of future equity awards if such approval was given. Effective August 11, 2011, the amendment to prohibit future stock options or other equity awards was approved by the Board.



At December 31, 2016 after reserving for stock options and deferred stock awards described in the two preceding paragraphs and adjusting for forfeitures and issuances during the year, there were 10,230 shares reserved for issuance under the Stock Plan. The Company has not awarded stock options or deferred stock under the Stock Plan since 2011.



Stock Options Outstanding



The following table summarizes changes in the number of outstanding stock options under the Director Plan, Stock Plan and the 2011 Incentive Plan during the three years ended December 31, 2016





 

 

 

 

 

 

 



 

 

 

 

 

 

 



 

 

Weighted average

 

Weighted average



 

 

exercise price

 

remaining



Options

 

per share

 

contractual term

Outstanding – December 31, 2013

309,439 

 

$

 

11.66 

 

4.13 years

Awarded

317,722 

 

 

 

12.30 

 

 

Exercised

(12,000)

 

 

 

8.28 

 

 

Forfeited

(74,757)

 

 

 

13.20 

 

 

Outstanding – December 31, 2014

540,404 

 

$

 

11.90 

 

5.13 years

Awarded

248,258 

 

 

 

11.31 

 

 

Exercised

(12,000)

 

 

 

10.21 

 

 

Forfeited

(54,738)

 

 

 

12.21 

 

 

Outstanding – December 31, 2015

721,924 

 

$

 

11.70 

 

4.89 years

Awarded

325,968 

 

 

 

6.66 

 

 

Exercised

 -

 

 

 

 -

 

 

Forfeited

(124,962)

 

 

 

10.39 

 

 

Outstanding – December 31, 2016

922,930 

 

 

 

10.10 

 

4.9 years



 

 

 

 

 

 

 

Exercisable at December 31, 2016

501,599 

 

$

 

11.30 

 

4.18 years

Expected to vest December 31, 2016

922,930 

 

 

 

10.10 

 

4.9 years



The fair value of awards issued under the Company’s stock option plan is estimated at grant date using the Black-Scholes option-pricing model.  The following table displays the assumptions used in the model.





 

 

 

 

 



 

 

 

 

 



Year Ended December 31



2016

 

2015

 

2014

Expected volatility

29.5% 

 

30.7% 

 

31.4% 

Risk free interest rate

1.5% 

 

1.6% 

 

2.7% 

Expected holding period

6 years

 

6 years

 

6 years

Dividend yield

9.1% 

 

5.7% 

 

5.2% 



Total unrecognized compensation expense was $168,000 as of December 31, 2016, which is expected to be recognized over the next 2.1 years.  The aggregate intrinsic value of all outstanding options, exercisable options, and options expected to vest (the amount by which the market price of the stock on the last day of the period exceeded the market price of the stock on the date of grant) was $0 based on the Company’s stock price at December 31, 2016.  The intrinsic value of options exercised during the year was $0, $10,000 and $40,000 in 2016,  2015 and 2014, respectively.  Net cash proceeds from the exercise of all stock options were $0, $0 and $99,000 for 2016,  2015 and 2014, respectively.  The following table summarizes the status of stock options outstanding at December 31, 2016:





 

 

 

 

 

 

 



 

 

 

 

 

 

 



 

 

 

Weighted Average

 

Weighted



 

 

 

Remaining

 

Average

Range of Exercise Prices

 

Shares

 

Option Life

 

Exercise Price

$5.50 to $7.99

 

289,200 

 

6.3 years

 

 

6.61 

$8.00 to $9.99

 

18,000 

 

2.4 years

 

 

9.73 

$10.00 to $12.00

 

466,824 

 

4.5 years

 

 

11.32 

$12.01 to $14.50

 

148,906 

 

3.7 years

 

 

13.07 



The Company receives an income tax benefit related to the gains received by officers and key employees who make disqualifying dispositions of stock received on exercise of qualified incentive stock options and on non-qualified options.  The amount of tax benefit received by the Company was $0, $4,000 and $14,000 in 2016,  2015 and 2014 respectively.  The tax benefit amounts have been credited to additional paid-in capital.



Deferred Stock Outstanding



The following table summarizes the changes in the number of deferred stock shares under the Stock Plan and 2011 Incentive Plan over the period December 31, 2013 to December 31, 2016:





 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

Weighted Average



 

 

 

 

Grant Date



 

 

Shares

 

Fair Value

Outstanding – December 31, 2013

 

 

200,140 

 

$

11.47 

Granted

 

 

48,824 

 

 

12.52 

Vested

 

 

(16,754)

 

 

13.81 

Forfeited

 

 

(70,896)

 

 

13.02 

Outstanding – December 31, 2014

 

 

161,314 

 

 

10.87 

Granted

 

 

103,017 

 

 

11.52 

Vested

 

 

(18,940)

 

 

12.37 

Forfeited

 

 

(118,964)

 

 

10.27 

Outstanding – December 31, 2015

 

 

126,427 

 

 

11.73 

Granted

 

 

102,161 

 

 

7.28 

Vested

 

 

(23,095)

 

 

11.36 

Forfeited

 

 

(56,233)

 

 

9.60 

Outstanding – December 31, 2016

 

 

149,260 

 

 

9.55 



The grant date fair value is calculated based on the Company’s closing stock price as of the grant date. As of December 31, 2016, the total unrecognized compensation expense related to the deferred stock shares was $171,000 and is expected to be recognized over a weighted-average period of 1.2 years.



Restricted Stock Units Outstanding



The following table summarizes the changes in the number of restricted stock units under the 2011 Incentive Plan over the period December 31, 2013 to December 31, 2016:





 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

Weighted Average



 

 

 

 

Grant Date



 

 

Shares

 

Fair Value

Outstanding – December 31, 2013

 

 

53,193 

 

$

10.44 

Granted

 

 

13,973 

 

 

11.98 

Vested

 

 

(28,015)

 

 

10.89 

Forfeited

 

 

 -

 

 

 -

Outstanding – December 31, 2014

 

 

39,151 

 

 

10.67 

Granted

 

 

20,979 

 

 

11.06 

Vested

 

 

(27,314)

 

 

10.08 

Forfeited

 

 

 -

 

 

 -

Outstanding – December 31, 2015

 

 

32,816 

 

 

11.41 

Granted

 

 

13,793 

 

 

6.33 

Vested

 

 

(19,023)

 

 

10.90 

Forfeited

 

 

(452)

 

 

11.05 

Outstanding – December 31, 2016

 

 

27,134 

 

 

8.65 



The grant date fair value is calculated based on the Company’s closing stock price as of the grant date. As of December 31, 2016, the total unrecognized compensation expense related to the restricted stock units was $33,000 and is expected to be recognized over a weighted-average period of 0.4 years.



Compensation Expense



Share-based compensation expense is recognized based on the fair value of awards granted over the vesting period of the award.  Share-based compensation expense recognized for 2016,  2015 and 2014 was $632,000, $899,000 and $785,000 before income taxes and $411,000, $584,000 and $510,000 after income taxes, respectively. Share-based compensation expense is recorded as a part of selling, general and administrative expenses.



Employee Stock Purchase Plan



Under the Company’s Employee Stock Purchase Plan (“ESPP”) employees are able to acquire shares of common stock at 85% of the price at the end of each current quarterly plan term.  The most recent term ended December 31, 2016.  The ESPP is considered compensatory under current rules.  At December 31, 2016, after giving effect to the shares issued as of that date, 76,865 shares remain available for purchase under the ESPP.



Employee Stock Ownership Plan (ESOP)



All eligible employees of the Company participate in the ESOP after completing one year of service.  Contributions are allocated to each participant based on compensation and vest 20% after two years of service and incrementally thereafter, with full vesting after six years.  At December 31, 2016, the ESOP held 595,959 shares of the Company’s common stock,  all of which have been allocated to the accounts of eligible employees. Contributions to the plan are determined by the Board of Directors and can be made in cash or shares of the Company’s stock. The 2016 ESOP contribution was $218,758 for which the Company will issue 47,248 shares in March 2016.  The 2015 ESOP contribution was $467,731 for which the Company issued 60,197 shares in 2016.  The Company’s 2014 ESOP contribution was $395,220 for which the Company issued 37,640 shares of common stock to the ESOP in 2015